{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"Unlocking RNA Secrets: Live Cell RNA Analysis Redefined with Dr. Marsha Hartman","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/af613d6a\"></iframe>","width":"100%","height":180,"duration":2922,"description":"In this episode, Dr. Marsha Hartman, Fractional CEO of Exodigm Biosciences, shares her journey from epidemiology to leading-edge biotech innovation. She explores how Exodigm’s breakthrough cell analysis technology is advancing personalized medicine and reshaping the future of diagnostics. The conversation dives into the lessons learned from COVID-19, the balance between science and strategy in leadership, and the ethical dimensions of AI in healthcare. Dr. Hartman also reflects on the importance of listening, collaboration, and purpose-driven work in creating meaningful impact across the life sciences.Chapters:00:00 Introduction to Marsha Hartman and Her Journey03:09 The Intersection of Epidemiology and Immunology06:00 Sales and Science: A Unique Blend09:13 COVID-19: A Case Study in Epidemiology and Immunology11:52 The Role of Biomarkers in Personalized Medicine15:02 Exodigm: Transforming Cell Analysis17:58 Marsha's Transition to CEO20:48 Leadership Philosophy and Personal Growth27:27 The Art of Listening in Leadership30:07 Lessons from COVID-19: A Global Experience34:01 The Role of Technology in Healthcare36:12 The Future of Personalized Medicine39:22 Patient Data Ownership and Accessibility42:20 The Ethical Use of AI in Healthcare44:23 Finding Your Purpose and Aligning with OthersGuest Information:Guest's Name: Dr. Marsha L. HartmanGuest's Title/Position:  Fractional CEOGuest's Linkedin: https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/Company / Affiliation:  Exodigm Biosciences https://www.exodigm.com/Guest's Bio: Dr. Marsha L. Hartman is the Fractional CEO of Exodigm Biosciences, a pioneering startup within the General Inception portfolio. At Exodigm, she is leading efforts to revolutionize cellular biology by enabling live single-cell analysis through transcriptomic insights — helping researchers and biomanufacturers work precisely with the cells they need. With a background in epidemiology and extensive leadership experience across diagnostics,...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}